| Post |
| Pre |
| LA |
|---|
| 1.7 |
| 1.9 |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 20.5 | 5.9 | 34.7 | 13.4 | 22.8 | 14.8 | - | - | - | - | 112.0 |
| 6.8 | 1.1 | 3.8 | 0.7 | 3.6 | 33.4 | - | - | - | - | 49.3 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 4,652 | 87.7% | -1.17 | 2,063 | 80.8% |
| Optic-unspecified(R) | 601 | 11.3% | -0.48 | 432 | 16.9% |
| LA(R) | 51 | 1.0% | 0.16 | 57 | 2.2% |
| upstream partner | # | NT | conns R7d | % In | CV |
|---|---|---|---|---|---|
| Dm9 (R) | 19 | Glu | 74.5 | 67.7% | 0.9 |
| R8d | 41 | HA | 30 | 27.3% | 0.6 |
| C2 (R) | 26 | GABA | 1.0 | 0.9% | 0.5 |
| Dm-DRA1 (R) | 20 | Glu | 0.9 | 0.8% | 0.6 |
| R7d | 9 | HA | 0.9 | 0.8% | 0.6 |
| MeLo2 (R) | 1 | ACh | 0.5 | 0.5% | 0.0 |
| L3 (R) | 12 | ACh | 0.4 | 0.4% | 0.6 |
| Cm11a (R) | 4 | ACh | 0.2 | 0.2% | 0.6 |
| Mi15 (R) | 6 | ACh | 0.2 | 0.2% | 0.3 |
| Dm-DRA2 (R) | 6 | Glu | 0.2 | 0.2% | 0.3 |
| Cm-DRA (R) | 2 | ACh | 0.2 | 0.2% | 0.7 |
| L1 (R) | 6 | Glu | 0.2 | 0.2% | 0.3 |
| Dm11 (R) | 5 | Glu | 0.1 | 0.1% | 0.3 |
| Lai (R) | 2 | Glu | 0.1 | 0.1% | 0.5 |
| MeTu3b (R) | 3 | ACh | 0.1 | 0.1% | 0.0 |
| MeTu2a (R) | 3 | ACh | 0.1 | 0.1% | 0.0 |
| MeTu2b (R) | 2 | ACh | 0.0 | 0.0% | 0.0 |
| L2 (R) | 2 | ACh | 0.0 | 0.0% | 0.0 |
| T1 (R) | 2 | HA | 0.0 | 0.0% | 0.0 |
| R8_unclear | 1 | HA | 0.0 | 0.0% | 0.0 |
| Mi19 (R) | 1 | unc | 0.0 | 0.0% | 0.0 |
| Mi9 (R) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| MeTu3c (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| MeTu3a (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| C3 (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| Cm11c (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| R1-R6 | 1 | HA | 0.0 | 0.0% | 0.0 |
| OA-AL2i3 (R) | 1 | OA | 0.0 | 0.0% | 0.0 |
| Cm11d (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| L5 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Dm2 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| l-LNv (R) | 1 | unc | 0.0 | 0.0% | 0.0 |
| downstream partner | # | NT | conns R7d | % Out | CV |
|---|---|---|---|---|---|
| Dm-DRA1 (R) | 26 | Glu | 50.9 | 24.8% | 0.4 |
| MeTu2a (R) | 36 | ACh | 28.7 | 14.0% | 0.6 |
| Dm9 (R) | 19 | Glu | 26.5 | 12.9% | 0.9 |
| R8d | 40 | HA | 17.1 | 8.3% | 0.6 |
| Dm2 (R) | 41 | ACh | 8.4 | 4.1% | 0.7 |
| L3 (R) | 47 | ACh | 7.0 | 3.4% | 0.6 |
| MeTu2b (R) | 15 | ACh | 6.8 | 3.3% | 0.6 |
| MeVP15 (R) | 11 | ACh | 6.8 | 3.3% | 0.7 |
| MeVPMe10 (R) | 2 | Glu | 6.2 | 3.0% | 0.6 |
| Cm14 (R) | 21 | GABA | 6.2 | 3.0% | 0.6 |
| Mi15 (R) | 37 | ACh | 6.0 | 2.9% | 0.6 |
| MeTu3a (R) | 16 | ACh | 5.1 | 2.5% | 0.9 |
| Cm-DRA (R) | 3 | ACh | 3.2 | 1.6% | 0.1 |
| MeTu3b (R) | 12 | ACh | 2.8 | 1.3% | 1.3 |
| Dm11 (R) | 10 | Glu | 2.6 | 1.3% | 0.7 |
| Cm11d (R) | 5 | ACh | 2.5 | 1.2% | 0.8 |
| Cm18 (R) | 9 | Glu | 2.0 | 1.0% | 0.6 |
| Mi1 (R) | 28 | ACh | 1.9 | 0.9% | 0.7 |
| L1 (R) | 30 | Glu | 1.8 | 0.9% | 0.6 |
| Tm_unclear (R) | 1 | ACh | 1.4 | 0.7% | 0.0 |
| Dm-DRA2 (R) | 12 | Glu | 1.1 | 0.5% | 0.7 |
| MeVP31 (R) | 1 | ACh | 0.9 | 0.4% | 0.0 |
| R7d | 10 | HA | 0.9 | 0.4% | 0.6 |
| L2 (R) | 16 | ACh | 0.7 | 0.3% | 0.9 |
| l-LNv (R) | 2 | unc | 0.5 | 0.3% | 0.9 |
| Cm21 (R) | 4 | GABA | 0.5 | 0.2% | 0.7 |
| Cm4 (R) | 8 | Glu | 0.5 | 0.2% | 0.6 |
| MeTu3c (R) | 3 | ACh | 0.5 | 0.2% | 0.6 |
| C2 (R) | 13 | GABA | 0.4 | 0.2% | 0.5 |
| T2 (R) | 9 | ACh | 0.4 | 0.2% | 0.6 |
| Dm8a (R) | 5 | Glu | 0.4 | 0.2% | 0.7 |
| Tm20 (R) | 12 | ACh | 0.4 | 0.2% | 0.3 |
| Cm28 (R) | 4 | Glu | 0.3 | 0.2% | 0.9 |
| Cm8 (R) | 6 | GABA | 0.3 | 0.2% | 0.7 |
| Mi2 (R) | 6 | Glu | 0.3 | 0.1% | 0.4 |
| Dm20 (R) | 5 | Glu | 0.3 | 0.1% | 0.7 |
| L5 (R) | 8 | ACh | 0.2 | 0.1% | 0.0 |
| MeVP6 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| C3 (R) | 5 | GABA | 0.2 | 0.1% | 0.6 |
| MeVPMe10 (L) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| T1 (R) | 5 | HA | 0.2 | 0.1% | 0.3 |
| Tm5c (R) | 4 | Glu | 0.2 | 0.1% | 0.2 |
| Dm8b (R) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| aMe12 (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| Cm22 (R) | 4 | GABA | 0.1 | 0.1% | 0.3 |
| Cm11b (R) | 2 | ACh | 0.1 | 0.1% | 0.3 |
| Mi4 (R) | 6 | GABA | 0.1 | 0.1% | 0.0 |
| MeLo2 (R) | 2 | ACh | 0.1 | 0.1% | 0.6 |
| Mi9 (R) | 5 | Glu | 0.1 | 0.1% | 0.0 |
| Dm10 (R) | 3 | GABA | 0.1 | 0.0% | 0.4 |
| Tm12 (R) | 4 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPMe6 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Lawf1 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| R1-R6 | 2 | HA | 0.1 | 0.0% | 0.3 |
| aMe4 (R) | 3 | ACh | 0.1 | 0.0% | 0.0 |
| Cm11a (R) | 2 | ACh | 0.1 | 0.0% | 0.3 |
| l-LNv (L) | 1 | unc | 0.0 | 0.0% | 0.0 |
| Cm35 (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| Tm1 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Lawf2 (R) | 2 | ACh | 0.0 | 0.0% | 0.0 |
| Dm4 (R) | 2 | Glu | 0.0 | 0.0% | 0.0 |
| Lai (R) | 2 | Glu | 0.0 | 0.0% | 0.0 |
| Dm1 (R) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| TmY18 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Mi16 (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| MeTu1 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Tm9 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| T2a (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Mi10 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Tm3 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| aMe17a (R) | 1 | unc | 0.0 | 0.0% | 0.0 |
| Tm5Y (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| MeVC20 (R) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| DNc01 (L) | 1 | unc | 0.0 | 0.0% | 0.0 |
| aMe5 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| L4 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| Tm37 (R) | 1 | Glu | 0.0 | 0.0% | 0.0 |